myStoria, a digital health platform focused on helping patients navigate complex reproductive care, has raised $1.625 million in seed funding to expand its AI-powered support system across the full reproductive health lifecycle. The round was led by Graphite Ventures, with participation from Conexus Venture Capital, Adrenaline Fund, Phoenix Fire Fund, and a group of angel investors.
The company is building infrastructure to support patients who are often forced to manage their own care across fragmented healthcare systems. This includes coordinating appointments, interpreting test results, tracking symptoms, and navigating insurance, responsibilities that typically fall outside formal medical support.
Founded by CEO Jessica Chalk, the company initially focused on fertility and IVF, areas known for long diagnostic delays and high dismissal rates. With the new funding, myStoria is expanding into broader reproductive and hormonal health conditions, including PCOS, endometriosis, and perimenopause.
At the core of the platform is a proprietary “Context Engine,” which aggregates and structures a patient’s complete health data, including medical records, symptoms, and appointment history, into a format optimized for AI. The system combines artificial intelligence with trained human professionals in a human-in-the-loop model, ensuring that guidance is both personalized and clinically grounded.
The funding will support three primary areas. First, the company will further develop its Context Engine and expand its curated medical knowledge base. Second, it will extend its care pathways across the reproductive health lifecycle with condition-specific support. Third, myStoria will scale its consumer offering through mobile apps on iOS and Android, using a freemium model to broaden access.
Investors view the company as more than a consumer health app, positioning it as a foundational infrastructure layer for patient-managed care. By organizing and retaining longitudinal health data, myStoria aims to become a central platform for ongoing health navigation.
While the company is currently focused on reproductive health, its long-term vision extends to other complex conditions such as cancer, heart disease, and autoimmune disorders, where patients similarly act as their own care coordinators.
KEY QUOTES:
“Reproductive health has the highest dismissal rates, the longest diagnostic delays, and the most fragmented care of any condition. That is why we started here. This funding lets us extend across the full lifecycle and build toward what we know this becomes. Nobody has ever built for the patient. Now we are. We are not fighting the system, we’re building the layer that was always missing from it.”
Jessica Chalk, Founder And CEO, myStoria
“What drew us to myStoria was their insight that complex healthcare is a burden failure, not just an information gap. The team has built a defensible infrastructure play, not just another consumer app. By owning the patient’s ‘Whole Story’ of patient data, they are positioned to become the primary navigation layer for life-long health management.”
Aaron Bast, GP, Graphite Ventures
“In complex care, patients are forced to become their own care coordinators, managing fragmented data, disconnected providers, and life-altering decisions with no real support. myStoria is built from a deep understanding of that reality. Jessica and her team are creating the patient-owned infrastructure the system has been missing. That’s what gives us conviction this can become a category-defining company.”
Alex Shimla, Principal, Conexus Venture Capital
